Lazard Asset Management
DERM icon

Lazard Asset Management’s Journey Medical DERM Stock Holding History

Lazard Asset Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$211K Sell
44,898
-17,627
-28% -$137K ﹤0.01% 1616
2025
Q4 		$482K Buy
+62,525
New +$490K ﹤0.01% 1386
2024
Q2 		– Sell
-251
Closed – – 2271
2024
Q1 		$0 Sell
251
-100
-28% -$435 ﹤0.01% 2113
2023
Q4 		$2K Buy
+351
New +$1.56K ﹤0.01% 2161

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Lazard Asset Management's DERM Position: Q1 2026 in Review

Lazard Asset Management reduced its Journey Medical (DERM) stake by 28% in Q1 2026, selling an estimated $137K and leaving 44,898 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #1616.

Lazard Asset Management first reported a position in DERM in Q4 2023 and has held it in 4 quarters since. The position peaked at $482K in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Lazard Asset Management held 44,898 shares of Journey Medical worth $211K as of Q1 2026.
  • Lazard Asset Management sold 17,627 Journey Medical shares in Q1 2026, an estimated $137K.
  • Journey Medical made up ﹤0.01% of Lazard Asset Management's portfolio in Q1 2026, its #1616 holding.
  • Lazard Asset Management first reported a position in Journey Medical in Q4 2023 and has held it in 4 quarters since.
  • Lazard Asset Management's Journey Medical position peaked at $482K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.